Navigation Links
Spherix Holds Annual Shareholders Meeting
Date:5/14/2008

orporate Officers was elected:

-- Paul Cox, Chairman of the Board

-- Claire Kruger, Chief Executive Officer and Chief Operating Officer

-- Robert Lodder, President

-- Robert Clayton, Interim Chief Financial Officer and Treasurer

-- Katherine Brailer, Corporate Secretary and Director of Administrative

Services

Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on October 10, 2007.

Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in biotechnology, and provides technical and regulatory consulting services to biotechnology and pharmaceutical companies.

Spherix's Internet address is http://www.spherix.com.


'/>"/>
SOURCE Spherix Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Spherix Hires Key Employees
2. Spherix Reports 2007 Financial Results
3. Spherix Reports 3rd Quarter Earnings
4. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
5. Sinovac Biotech Holds Annual General Meeting
6. New Robotic Imaging Technology Holds Promise of Improved Cancer Care
7. Vion Pharmaceuticals Holds Special Meeting of Stockholders
8. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
9. Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing
10. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
11. CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)... Science,s Survey Criteria Included a Focus on Res... People, INDIANAPOLIS, Oct. 10 /PRNewswire-Fir...ounced today that it has made the list of Top 20,b...igious peer-reviewed,journal Science. Science,s 20...mployers in the biotechnology, biopharmaceutical, ...
(Date:10/10/2008)... ROCKVILLE, Md., Oct. 10 /... pharmaceutical company developing,therapeutics fo...s,announced today that Thomas H. Bliss, Jr., Entr...ss Development, will present a Company,overview at...which is being,held October 12-14, 2008 in London,...
(Date:10/9/2008)..., The race for the best "gecko foot" dry adhesive ... more practical material reported in the journal S...titutions. , Scientists have long been intereste...ls and cling to ceilings by their toes. The creat...hed elastic hairs in their toes that take advantag...
(Date:10/9/2008)... Achieves Positive Operating Income Excluding ...irstCall/ -- CardioDynamics (Nasdaq:,CDIC), the in...hy (ICG),technology, today reported financial resu...ights of Third Quarter 2008 Compared with Third Qu...million, up from $5.6 million -- International sa...
Breaking Biology Technology:Lilly Recognized as One of the World's Top Biopharmaceutical Employers 2EntreMed to Present at BioPartnering Europe Conference 2EntreMed to Present at BioPartnering Europe Conference 3Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 2Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 3Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 4CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 3CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 4CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 5CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 6
...and Mass Spectrometry Application Note , ...rmo Electron Corporation, San Jose, CA, USA , ...ard (DS) concept was introduced more than 40 years...y of process chromatography. The DS consists of an...phic run. The DS injection is deferred from the sa...
...erry Zhang, and Ken Miller; , Thermo Ele...s Sensitivity Proteomics Finnigan LCQ Deca XP P...S/MS , Introduction , Detectio...wnward to levels no one would have thought possibl...by instrument hardware improvements and sophistica...
..., Lynn Jordan, and Ed Alderman , Applied...ciences, Inc., Hopkinton, MA 01748 , Kare...oscience Corporation, 100 Cummings Center, Suite 1..., The goal for plasmid purification is isol... can be accomplished through the use of the SPRI-b...
...n , A calcium flux assay has been develop...e in drug screening against GPCR targets. The mini...ent consumption, high data quality and a high degr...ic assay accesses test compounds from a microplate...uously flowing through the chip. Flow through the ...
Other Biology Technology:Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard 2Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard 3Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard 4Fully Automated Nano-Electrospray Coupled with a Finnigan LCQ Deca XP Plus for Sub-fmol Proteomic Analysis 2Fully Automated Nano-Electrospray Coupled with a Finnigan LCQ Deca XP Plus for Sub-fmol Proteomic Analysis 3Fully Automated Nano-Electrospray Coupled with a Finnigan LCQ Deca XP Plus for Sub-fmol Proteomic Analysis 4Fully Automated Nano-Electrospray Coupled with a Finnigan LCQ Deca XP Plus for Sub-fmol Proteomic Analysis 5High Throughput Plasmid DNA Preparation Using A Magnetic Bead Kit On An Automated Workstation 2High Throughput Plasmid DNA Preparation Using A Magnetic Bead Kit On An Automated Workstation 3Calcium Flux Assays using the LabChip 3000 2Calcium Flux Assays using the LabChip 3000 3Calcium Flux Assays using the LabChip 3000 4Calcium Flux Assays using the LabChip 3000 5Calcium Flux Assays using the LabChip 3000 6Calcium Flux Assays using the LabChip 3000 7
(Date:10/10/2008)...ientists have created nanowire sensors coupled wit...sensitive and specific enough to be used for point...eport in Nano Letters . , The sensors use activ... signatures of bacteria, viruses or cancer cells ...produce acid, and generate a tiny current in the n...
(Date:10/9/2008)...t. 9 /PRNewswire-FirstCall/ -- Synaptics(R),Incorp...man interface,solutions for mobile computing, comm...oday that it will report financial results for the... 23, 2008 after the close of market. The,company w...sts and,investors at 2:00 p.m. PT (5:00 p.m. ET) d...
(Date:10/9/2008)...sel: you have to worry about hungry starfish and e... that can change your body temperature 50 degrees ...he most variable habitats on Earth," said USC biol...e day bathed in cool Pacific seawater and the othe... led the first real-time molecular sampling of mus...
(Date:10/9/2008)... Allergy and Infectious Diseases (NIAID), part of ...d five-year contracts estimated to be up to $68.7 ...or Infectious Disease Research at four research in... novel techniques to study diseases that include s...sis and influenza. , Systems biology is the stud...
Breaking Biology News(10 mins):Sensitive nanowire disease detectors made by Yale scientists 2Synaptics to Report First Quarter Results on October 23 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3New Systems Biology Awards enable detailed study of microbes 2Ardea Biosciences Lead NNRTI for HIV RDEA806 to Enter Phase 2a Proof of Concept Clinical Trial 8941 1Ardea Biosciences Lead NNRTI for HIV RDEA806 to Enter Phase 2a Proof of Concept Clinical Trial 8941 2Ardea Biosciences Lead NNRTI for HIV RDEA806 to Enter Phase 2a Proof of Concept Clinical Trial 8941 3Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets 28OTC 29 5mg and 10mg 8938 1Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets 28OTC 29 5mg and 10mg 8938 2Drug Safety Tainted Food Among Years Top Health Stories 8936 1Drug Safety Tainted Food Among Years Top Health Stories 8936 2Drug Safety Tainted Food Among Years Top Health Stories 8936 3Drug Safety Tainted Food Among Years Top Health Stories 8936 4Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules 2406 1
...n culture to mimic the properties of the heart hav...hanisms that spawn irregular heart rhythms. Studie...hile electric shocks such as those delivered by de...me cases they cause them to accelerate and multipl...ity team, led by Nenad Bursac of Duke,s Pratt Scho...
..., have announced the Food and Drug Administration,...air that incorporates a biodegradable technology d...paradigm shift in the application of biomaterials ...nerative medicine, in which materials help the bod...evice consists of a surgical mesh coated with a po...
...se-causing invader that creates a fuzzy gray coati... gene provides access to a different type of patho...st and his collaborators in Austria and North Caro...ze pathogens and also triggers a defense against d...milar to an immunity pathway found in people and i...
...tists at the University of Oslo have recently disc...he goldfish, is able to live for months without ox...some animals cope with a lack of oxygen might give..., "Anoxia related diseases are the major causes of... situation where evolution has solved the problem ...
Other Biology News:Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 2Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 3FDA approves first medical device using rutgers biomaterial 2Gene thwarts some pathogens, gives access to others, could save crops 2Gene thwarts some pathogens, gives access to others, could save crops 3
Request Info
Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles
fli-1
Biology Products: